Its gene product, BRG1, has been suggested as a lung cancer transcriptional regulator of genes that induce tumour proliferation (Dagogo-Jack et al., 2020) and metastasis (Concepcion et al., 2022). Here, SMARCA4 is linked to lung carcinoma.